Aller au contenu principal
Accueil

National Network for Equitable Library Service

Le système canadien de la bibliothèque accessible (D10 Beta)

Menu
  • English
  • Français

User menu

  • Se connecter
Sign Up Login

Faire une recherche dans le catalogue:

Main menu

  • Accueil
  • Tutorials
  • Info for Libraries
  • Grant Projects
  • News
  • About

Fil d'Ariane

  1. Accueil
  2. Acceptable Risk

Acceptable risk

Available Formats:

Details:

  • Auteur: Cook, Robin
    Résumé:

    The bestselling “master of the medical thriller” (The New York Times) confronts one of the most compelling issues of our time: personality-altering drugs and the complex moral questions they raise. When neuroscientist Edward Armstrong begins dating Kimberly Stewart, a descendant of a woman who was hanged as a witch at the time of the Salem witch trials, he takes advantage of the opportunity to delve into a pet theory: that the “devil” in Salem in 1692 had been a hallucinogenic drug inadvertently consumed with mold-tainted grain. In an attempt to prove his theory, Edward grows the mold he believes responsible with samples from the Stewart estate. In a brilliant designer-drug transformation, the poison becomes Ultra, the next generation of antidepressants with truly startling therapeutic capabilities. But who can be sure the drug is safe for consumers? Who defines the boundaries of “normal” human behavior? And if the drug’s side effects are proven to be dangerous—even terrifying—how far will the medical community go to alter their standards of acceptable risk?

    Genre: Medical fiction, Thrillers (Fiction)
    Original Publisher: New York , G.P. Putnam's Sons , New York , Putnam
    Language(s): English
    ISBN:

    9781101203552

Details

Abstract

The bestselling “master of the medical thriller” (The New York Times) confronts one of the most compelling issues of our time: personality-altering drugs and the complex moral questions they raise. When neuroscientist Edward Armstrong begins dating Kimberly Stewart, a descendant of a woman who was hanged as a witch at the time of the Salem witch trials, he takes advantage of the opportunity to delve into a pet theory: that the “devil” in Salem in 1692 had been a hallucinogenic drug inadvertently consumed with mold-tainted grain. In an attempt to prove his theory, Edward grows the mold he believes responsible with samples from the Stewart estate. In a brilliant designer-drug transformation, the poison becomes Ultra, the next generation of antidepressants with truly startling therapeutic capabilities. But who can be sure the drug is safe for consumers? Who defines the boundaries of “normal” human behavior? And if the drug’s side effects are proven to be dangerous—even terrifying—how far will the medical community go to alter their standards of acceptable risk?

Genre
Medical fiction
Thrillers (Fiction)
Publisher (Source)

New York

G.P. Putnam's Sons

New York

Putnam

Non spécifié

Record

Main menu

  • Accueil
  • Tutorials
  • Info for Libraries
  • Grant Projects
  • News
  • About

Questions sur RNSEB? Contactez-nous!

Par courriel: support@nnels.ca

Téléphone: 1-888-848-9250

Suivez-nous : Bluesky, Facebook, YouTube, Linkedin

Abonnez-vous à notre newsletter.

Quatre silhouettes bleues font signe de la main, deux adultes et deux enfants, avec le texte « employeur garantissant un salaire minimum vital

Logo du Consortium pour les livres accessibles, représentant un livre ouvert avec les lettres A, B et C en texte et en braille. Logo Daisy, deux courbes bleues au-dessus et en dessous du mot DAISY Le logo du European Digital Reading Lab, un cercle bleu avec « EDRLab » au centre.